The expression of CXCR2 is predominantly high in solid tumors, including NB, and is known to control the regulation of the PI3K/AKT, ERK1/2, NF-κB, and JAK/STAT pathways [24,25]. This evidence concerns the gene MAPK3 and neuroblastoma.